Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies

BACKGROUND: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Prins, Martin H, Lensing, Anthonie WA, Bauersachs, Rupert, van Bellen, Bonno, Bounameaux, Henri, Brighton, Timothy A, Cohen, Alexander T, Davidson, Bruce L, Decousus, Hervé, Raskob, Gary E, Berkowitz, Scott D, Wells, Philip S
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Original Clinical Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3850944/
https://ncbi.nlm.nih.gov/pubmed/24053656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-11-21
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires